Invivo Therapeutics Holdings Corp Stock Nasdaq
Equities
US46186M2098
Advanced Medical Equipment & Technology
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.5M 6.17M |
---|---|---|---|---|---|
Net income 2021 | -9M -12.33M | Net income 2022 | -10M -13.7M | EV / Sales 2021 | - |
Net cash position 2021 | 17.72M 24.28M | Net cash position 2022 | 15.4M 21.1M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.52
x | P/E ratio 2022 |
-0.34
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
1st Jan change | Capi. | |
---|---|---|
+7.69% | 219B | |
+5.62% | 183B | |
+10.43% | 132B | |
+23.34% | 106B | |
-2.66% | 62.09B | |
+4.81% | 50.88B | |
+11.09% | 50.8B | |
-0.87% | 40.64B | |
+24.87% | 31.59B |